Publicaciones científicas

/cun/investigacion/publicaciones-cientificas/areaMain/02
  • Risk of complications in patients with conservatively managed ovarian tumours (IOTA5)

    Froyman W (1), Landolfo C (2), De Cock B (3), Wynants L (3), Sladkevicius P (4), Testa AC (5), Van Holsbeke C (6), Domali E (7), Fruscio R (8), Epstein E (9), Dos Santos Bernardo MJ (10), Franchi D (11), Kudla MJ (12), Chiappa V (13), Alcazar JL (14), Leone FPG (15), Buonomo F (16), Hochberg L (17), Coccia ME (18), Guerriero S (19), Deo N (20), Jokubkiene L (4), Kaijser J (21), Coosemans A (22), Vergote I (22), Verbakel JY (23), Bourne T (24), Van Calster B (25), Valentin L (4), Timmerman D (26)

    (1) Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium.
    (2) Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK.
    (3) Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
    (4) Department of Obstetrics and Gynecology, Skåne University Hospital Malmö, Lund University, Sweden.
    (5) Department of Woman and Child Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore Roma, Rome, Italy.
    (6) Department of Obstetrics and Gynecology, Ziekenhuis Oost-Limburg, Genk, Belgium.
    (7) First Department of Obstetrics and Gynecology, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
    (8) Clinic of Obstetrics and Gynecology, University of Milan-Bicocca, San Gerardo Hospital, Monza, Italy.
    (9) Department of Clinical Science and Education, Karolinska Institutet and Department of Obstetrics and Gynecology, Södersjukhuset, Stockholm, Sweden.
    (10) Department of Obstetrics and Gynecology, Centro Hospitalar Lisboa Central, Lisbon, Portugal.
    (11) Preventive Gynecology Unit, Division of Gynecology, European Institute of Oncology IRCCS, Milan, Italy.
    (12) Department of Perinatology and Oncological Gynecology, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
    (13) Department of Gynecologic Oncology, National Cancer Institute of Milan, Milan, Italy.
    (14) Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, School of Medicine, Pamplona, Spain.
    (15) Department of Obstetrics and Gynecology, Biomedical and Clinical Sciences Institute L. Sacco, University of Milan, Milan, Italy.
    (16) Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", Trieste, Italy.
    (17) Imaged Based Gynecology Service, Department of Obstetrics and Gynecology, University of South Florida Morsani College, Tampa, FL, USA.
    (18) Department of Obstetrics and Gynecology, University of Florence, Florence, Italy.
    (19) Department of Obstetrics and Gynecology, University of Cagliari, Policlinico Universitario Duilio Casula, Monserrato, Cagliari, Italy.
    (20) Department of Obstetrics and Gynaecology, Whipps Cross Hospital, London, UK.
    (21) Department of Obstetrics and Gynecology, Ikazia Hospital, Rotterdam, Netherlands.
    (22) Department of Oncology, Leuven Cancer Institute, Laboratory of Tumor Immunology and Immunotherapy, ImmunOvar Research Group, KU Leuven, Leuven, Belgium; Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium.
    (23) Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
    (24) Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium; Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK.
    (25) Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, Netherlands.
    (26) Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium.

    Lancet Oncology 05 de FEBRERO de 2019

  • Pre-operative assessment of intra-abdominal disease spread in epithelial ovarian cancer: a comparative study between ultrasound and computed tomography

    Alcázar JL (1), Caparros M (2), Arraiza M (3), Mínguez JÁ (2), Guerriero S (4), Chiva L (2), Jurado M (2)

    (1) Department of Obstetrics and Gynecology, Clínica Universidad de Navarra, Pamplona, Spain.
    (2) Department of Obstetrics and Gynecology, Clínica Universidad de Navarra, Pamplona, Spain.
    (3) Department of Radiology, Clínica Universidad de Navarra, Pamplona, Spain.
    (4) Department of Obstetrics and Gynecology, University of Cagliari, Policlinico Universitario Duilio Casula, Monserrato, Italy.

    International Journal of Gynecological Cancer 10 de ENERO de 2019

  • Prospective external validation of IOTA three-step strategy to characterize and classify adnexal masses

    Hidalgo JJ (1,2), Ros F (2), Aubá M (3), Errasti T (3), Olartecoechea B (3), Ruiz-Zambrana Á (3), Alcázar JL (3).

    (1) Department of Obstetrics and Gynecology, Hospital Clínico Universitario de Valencia, Valencia, Spain.
    (2) Unidad Predepartamental de Medicina. Universitat Jaume I. Castellón, Spain.
    (3) Department of Obstetrics and Gynecology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.

    Ultrasound Obstetric Gynecology 24 de OCTUBRE de 2018

  • Endometrial cancer off-line staging using two-dimensional transvaginal ultrasound and three-dimensional volume contrast imaging

    Green RW (1), Valentin L (2), Alcazar JL (3), Chiappa V (4), Erdodi B (5), Franchi D (6), Frühauf F (7), Fruscio R (8), Guerriero S (9), Graupera B (10), Jakab A (5), di Legge A (11), Ludovisi M (11), Mascilini F (11), Pascual MA (10), van den Bosch T (12), Epstein E (13).

    (1) Karolinska Institute, Department of Women's and Children's Health, Karolinska Universitetssjukhuset, Byggnad H2:00, 17165 Stockholm, Sweden.
    (2) Department of Obstetrics and Gynecology, Skåne University Hospital, Malmö, Lund University, Sweden.
    (3) Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, Pamplona, Spain.
    (4) Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
    (5) Department of Obstetrics and Gynecology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
    (6) Department of Preventive Gynecology, European Institute of Oncology, Milan, Italy.
    (7) Gynecological Oncology Centre, Department of Obstetrics and Gynecology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
    (8) Clinic of Obstetrics and Gynecology, Department of Medicine and Surgery, San Gerardo Hospital, University of Milan-Bicocca, Monza, Italy.
    (9) Department of Obstetrics and Gynecology, Azienda Ospedaliero Universitaria-Policlinico Duilio Casula, University of Cagliari, Cagliari, Italy.
    (10) Department of Obstetrics, Gynecology and Reproduction, Hospital Universitario Dexeus, Barcelona, Spain.
    (11) Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome, Italy.
    (12) Department of Obstetrics and Gynecology, University Hospital Leuven, Leuven, Belgium.
    (13) Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.

    Gynecologic Oncology 03 de SEPTIEMBRE de 2018

  • Riesgo de cáncer de endometrio e hiperplasia endometrial con atipia en mujeres posmenopáusicas asintomáticas con grosor endometrial ≥11 mm

    Alcázar JL (1), Bonilla L (2), Marucco J (3), Padilla AI (4), Chacón E (1), Manzour N 1, Salas A (1).

    (1) Department of Obstetrics and Gynecology, Clínica Universidad de Navarra, School of Medicine, University of Navarra, Pamplona, Spain.
    (2) Department of Obstetrics and Gynecology, University Hospital Virgen de las Nieves, Granada, Spain.
    (3) Centro de Diagnóstico TCBA, Buenos Aires, Argentina.
    (4) Department of Obstetrics and Gynecology, Canaty Islands University Hospital, Tenerife, Spain.

    Journal Clinical of Ultrasound 16 de AGOSTO de 2018

tal vezLE INTERESE

¿QUÉ TECNOLOGÍA UTILIZAMOS?

La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

NUESTROS
PROFESIONALES

Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen profesionales de la Clínica Universidad de Navarra

POR QUÉ VENIR
A LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra